Skip to main content

Ming Chen

Associate Professor of Pathology
Pathology

Selected Grants


Developing A Novel Combinatorial Therapy for Lethal Neuroendocrine Prostate Cancer

ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2022 - 2027

Targeting Ferroptosis in Lethal RB1 Deficient Prostate Cancer

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2027

Engineering Large Chromosomal Deletions in Mice to Advance Precision Oncology for Prostate Cancer

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2027

Targeting NUAK2 in neuroendocrine prostate cancer

ResearchCo Investigator · Awarded by Department of Defense · 2023 - 2026

Cell and Molecular Biology Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026

Developing A Novel Combinatorial Therapy for Lethal Neuroendocrine Prostate Cancer

ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2022 - 2027

Targeting Ferroptosis in Lethal RB1 Deficient Prostate Cancer

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2027

Engineering Large Chromosomal Deletions in Mice to Advance Precision Oncology for Prostate Cancer

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2027

Targeting NUAK2 in neuroendocrine prostate cancer

ResearchCo Investigator · Awarded by Department of Defense · 2023 - 2026

Cell and Molecular Biology Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026

Exploiting Ferroptosis for the Treatment of RB1-Deficient Lethal Prostate Cancer

ResearchMentor · Awarded by Department of Defense · 2022 - 2024

Targeting NUAK2 to mitigate obesity-enhanced prostate cancer growth and metastasis

ResearchCo Investigator · Awarded by Department of Defense · 2021 - 2024

De Novo Lipogenesis and Chemosensitivity of Prostate Cancer

ResearchPrincipal Investigator · Awarded by Department of Defense · 2020 - 2023

Exploiting ferroptosis for the treatment of lethal neuroendocrine prostate cancer

ResearchPrincipal Investigator · Awarded by Mike Slive Foundation · 2021 - 2021

Fellowships, Gifts, and Supported Research


Leukemia & Lymphoma Society Special Fellow Award (declined) · 2012 - 2015 Leukemia & Lymphoma Society
Department of Defense Prostate Cancer Research Program Postdoctoral Fellowship Award · 2012 - 2014 the Department of Defense (DoD)
Lung Cancer Research Foundation (LCRF) Grant Award · 2011 - 2012 Lung Cancer Research Foundation